Blog & News
Stay up to date with the latest research, lab tips, and industry news.
Zechin Bio Achieves ISO 13485:2016 Certification
Zechin Bio has officially achieved ISO 13485:2016 certification, marking the company's full upgrade from a research reagent supplier to an IVD raw material provider.
Read more →
How to Choose the Right Agarose: A Complete Selection Guide
Electroendosmosis, gel strength, resolution, melting point — four key parameters determine experimental success. This article systematically reviews the selection logic of 5 major agarose categories.
Read more →
New Launch: Full Range of Zechin™ Prepacked Columns
After 18 months of R&D, Zechin Bio launches prepacked columns covering GST, MBP, NINTA, Q anion exchange, and SP cation exchange modes in 1 mL and 5 mL formats, ready to use out of the box.
Read more →
Protein Purification Media Selection: From Lab Screening to Process Scale-Up
Using a typical His-tagged recombinant protein purification as a case study, this article explains how to select the most suitable chromatography media based on target protein properties.
Read more →
Top 10 Common Agarose Gel Electrophoresis Problems and Solutions
Smearing, band curvature, smiling, ghost bands — this article summarizes 10 most common agarose electrophoresis problems with 3 troubleshooting steps each.
Read more →
Impact of Cold Chain Logistics on Biological Reagent Activity
Enzymes, antibodies, cytokines are extremely temperature-sensitive. This article shares Zechin Bio's global cold chain practice, covering temperature control from warehouse to customer lab.
Read more →
BIOCHINA 2026 Recap: Zechin Bio Booth Draws Record Crowds
The 3-day BIOCHINA 2026 in Suzhou has concluded. Zechin Bio publicly debuted 7 agarose categories and 5 prepacked column series, engaging 800+ clients and securing over 20M RMB in intended orders.
Read more →
Critical Role of GMP-Grade Raw Materials in Biopharma Manufacturing
From IND filing to commercial production, GMP-grade raw material selection directly impacts regulatory compliance, batch consistency, and final drug quality. This article systematically reviews 4 key selection dimensions from a regulatory perspective.
Read more →